rss

AstraZeneca Covid-19 vaccine – study put on hold due to suspected adverse reaction in trial participant

The Phase 3 study testing the AstraZeneca and the University of Oxford COVID-19 vaccine has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.

Spokesperson for AstraZeneca
  • standard review process triggered a pause to vaccination to allow review of safety data
  • “a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”
Risk negative, but so far little response. Eyes on the tech rout still. Globex equity index future trade reopens at the top of this hour.
coronavirus

ICYMI: Scientists question results from a study of Russia’s coronavirus vaccine

Taking a detour from the tech stock rout for just a moment, this on the much-touted Russian COVID-19 vaccine.

Via Bloomberg.
A group of international scientists say some of the published findings that appeared in the Lancet appeared improbable.
  • flagged concerns over seemingly identical levels of antibodies in a number of study participants who were inoculated with the experimental vaccine
  • This and other patterns in the data present “several different points of concern”
The link above has more. Is anyone surprised by this?
Taking a detour from the tech stock rout for just a moment, this on the much-touted Russian COVID-19 vaccine.